HHMI
CRH icon

Howard Hughes Medical Institute’s CRH CRH Stock Holding History

Howard Hughes Medical Institute’s Portfolio CRH Stock Details CRH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-144
Closed -$18K – 136
2025
Q4 		$18K Buy
+144
New +$17.2K 0.01% 122

Other funds holding CRH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Howard Hughes Medical Institute's CRH Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of CRH (CRH) in Q1 2026, closing a stake of 144 shares — an estimated $18K sold.

Howard Hughes Medical Institute first reported a position in CRH in Q4 2025 and held it in 1 quarter. The position peaked at $18K in Q4 2025. 1,007 funds tracked by Wall St. Rank hold CRH as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining CRH position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 144 CRH shares in Q1 2026, an estimated $18K.
  • Howard Hughes Medical Institute first reported a position in CRH in Q4 2025 and held it in 1 quarter.
  • Howard Hughes Medical Institute's CRH position peaked at $18K in Q4 2025.
  • 1,007 funds tracked by Wall St. Rank held CRH as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.